BioIVT Supports Non-CYP Metabolism Research with Hepatocyte Grants
July 8, 2025
Company empowers ADME, hepatobiology, and toxicity research toward the goal of reducing the risk of adverse drug effects BALTIMORE -- BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the opening of its Hepatocyte Grants Program and that it is actively reviewing research proposals. As a leader in [...]
July 8, 2025
BURLINGAME, Calif. — Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, and deepmirror, the AI drug design platform that empowers chemists to focus on more promising drug molecules, today announced a strategic partnership integrating deepmirror with CDD Vault to enhance drug discovery. CDD Vault helps research teams [...]
Cresset Acquires Molab.ai to Advance Digitization of Drug Discovery
July 8, 2025
Cambridge UK – Cresset, a leading provider of innovative solutions for the digitization of drug discovery, announces the acquisition of Molab.ai, a pioneer in artificial intelligence technologies tailored for molecular research. This strategic acquisition will combine Cresset’s powerful computational chemistry platform with Molab.ai’s proven capability to build highly predictive ADME models. It marks a significant [...]
Datacolor Acquires TECHKON USA, Deepening Print and Packaging Industry Presence
July 8, 2025
LAWRENCEVILLE, N.J. – Datacolor, a global leader in color management software, instruments and services, today announced the acquisition of TECHKON USA, based in Danvers, Mass. Albert Busch, president and CEO of Datacolor, stated, “Building on the recent acquisition of Techkon GmbH, this acquisition allows Datacolor to broaden its market reach and product offering with Techkon USA’s [...]
July 8, 2025
Smart Spectral Processing seamlessly integrates FTIR and Raman technologies into a single, intuitive workflow BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the launch of VipIR, a 3-in-1 handheld analyzer that sets a new standard for rapid and confident field-based chemical identification of unknown bulk solids and liquids, [...]
Rigaku Announces STAvesta, a Thermal Analyzer Tailor-made for Next-generation Material Development
July 8, 2025
Supports a wide range of users from novices to experts, serving a wide variety of needs TOKYO -- Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has launched worldwide sales of STAvesta, a thermal analyzer that simultaneously measures a sample’s weight and change in calorific value [...]
Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth
July 8, 2025
Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high [...]
July 8, 2025
BILLERICA, Mass. -- Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets. Under the terms of [...]
July 8, 2025
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies SEATTLE, Wash. — The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical [...]
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
July 7, 2025
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum™ ddPCR system along with the QX700™ series of ddPCR platforms acquired as part of the company’s recently [...]

